IRIS
BUTTINI, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.004
AS - Asia 4.365
EU - Europa 3.620
SA - Sud America 725
AF - Africa 199
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 6
Totale 13.951
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.878
SG - Singapore 1.733
CN - Cina 1.377
IT - Italia 744
IE - Irlanda 724
BR - Brasile 589
SE - Svezia 479
HK - Hong Kong 399
FI - Finlandia 371
DE - Germania 336
VN - Vietnam 315
NL - Olanda 215
TR - Turchia 154
FR - Francia 153
ZA - Sudafrica 152
UA - Ucraina 137
GB - Regno Unito 118
RU - Federazione Russa 96
IN - India 76
AT - Austria 75
CA - Canada 74
AR - Argentina 72
KR - Corea 68
BD - Bangladesh 53
ID - Indonesia 39
ES - Italia 38
JP - Giappone 37
MX - Messico 36
BE - Belgio 28
PL - Polonia 25
AU - Australia 24
IQ - Iraq 21
EC - Ecuador 20
CZ - Repubblica Ceca 18
PK - Pakistan 14
CI - Costa d'Avorio 13
MA - Marocco 13
PY - Paraguay 13
RS - Serbia 12
CO - Colombia 11
UZ - Uzbekistan 11
PT - Portogallo 9
TW - Taiwan 9
CL - Cile 8
KE - Kenya 8
LT - Lituania 8
MY - Malesia 8
NZ - Nuova Zelanda 8
AE - Emirati Arabi Uniti 7
HU - Ungheria 6
AZ - Azerbaigian 5
BO - Bolivia 5
EU - Europa 5
IR - Iran 5
VE - Venezuela 5
CH - Svizzera 4
JM - Giamaica 4
KZ - Kazakistan 4
TH - Thailandia 4
CR - Costa Rica 3
EE - Estonia 3
HR - Croazia 3
JO - Giordania 3
PA - Panama 3
PS - Palestinian Territory 3
QA - Qatar 3
RO - Romania 3
TN - Tunisia 3
AL - Albania 2
BH - Bahrain 2
BY - Bielorussia 2
DZ - Algeria 2
ET - Etiopia 2
IL - Israele 2
LB - Libano 2
LU - Lussemburgo 2
MK - Macedonia 2
OM - Oman 2
PE - Perù 2
SA - Arabia Saudita 2
AD - Andorra 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
Totale 13.944
Salva come PNG Salva come JPEG
Città #
Singapore 849
Dublin 717
Ashburn 698
Chandler 627
Santa Clara 413
Hong Kong 398
Dallas 394
Beijing 354
Dearborn 220
Parma 217
Boardman 177
Jacksonville 163
Ann Arbor 150
Nanjing 147
Johannesburg 146
Princeton 116
Shanghai 113
Ho Chi Minh City 108
Izmir 107
Munich 104
Los Angeles 99
Hefei 97
Wilmington 92
Milan 71
Hanoi 70
Columbus 67
Seoul 65
Helsinki 64
Moscow 63
New York 57
Vienna 55
São Paulo 48
Bremen 46
Seattle 42
Shenyang 42
San Mateo 41
Bologna 39
Chicago 38
Nanchang 38
Buffalo 35
The Dalles 34
Changsha 33
Groningen 33
Turku 33
Kunming 32
London 31
Woodbridge 31
Council Bluffs 30
Hebei 30
Jiaxing 30
Guangzhou 29
Jakarta 27
Tianjin 27
Des Moines 26
Rome 26
Toronto 26
Brooklyn 25
Brussels 25
Houston 25
Jinan 25
Frankfurt am Main 24
Marseille 24
Falls Church 23
Reggio Emilia 23
Tokyo 22
Stockholm 21
Warsaw 21
Ardea 20
Sydney 20
Amsterdam 18
Ferrara 18
Montreal 17
Norwalk 17
Pune 16
Rio de Janeiro 16
Fremont 15
Haiphong 15
Istanbul 15
Phoenix 15
Atlanta 14
Chennai 14
Da Nang 14
Mexico City 14
Abidjan 13
Grafing 13
Kocaeli 13
Porto Alegre 13
San Francisco 13
Manchester 12
Nuremberg 12
Belo Horizonte 11
Brno 11
Bắc Ninh 11
Düsseldorf 11
Formigine 11
Padova 11
Denver 10
Hangzhou 10
Belgrade 9
Orem 9
Totale 8.574
Salva come PNG Salva come JPEG
Nome #
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 219
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa 188
Nano-adjuvanted dry powder vaccine for the mucosal immunization against airways pathogens 183
Opportunity and challenges of nasal powders: Drug formulation and delivery 179
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease 165
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 160
CHIMERAL AGGLOMERATES OF MICRONIZED POWDER FOR NASAL ADMINISTRATION OF ANALGESIC DRUG 158
Nebulizers effectiveness on pulmonary delivery of alpha-1 antitrypsin 152
Solid-state characterization of tobramycin powders for inhalation 150
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 146
Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers 144
Chimeral agglomerates of microparticles for the administration of caffeine nasal powders 143
The Impact of Possible Misuses Conditions on in Vitro Performance of NEXThaler in Comparison with Ellipta Inhaler 141
Agglomerates of Morphine Microcrystals for Nasal or Buccal Administration 141
Accessorized DPI: a Shortcut towards Flexibility and Patient Adaptability in Dry Powder Inhalation 138
A respirable HPV-L2 dry-powder vaccine with GLA as amphiphilic lubricant and immune-adjuvant 136
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 135
Aerosolization performance of jet nebulizers and biopharmaceutical aspects 135
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients 132
Crystalline Microparticles of a Beta-Agonist Coated with a Fatty Acid 129
Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers 129
High shear mixing of lactose and salmeterol xinafoate dry powder blends: biopharmaceutic and aerodynamic performances 127
Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections 127
The use of multilayer poly(vinyl alcohol) adsorption to fabricate drug rich inhalable microparticles. 125
A Clinical Study of a Methacholine Dry Powder for the Bronchial Challenge Test 125
A DRUG POWDER FOR INHALATION ADMINISTRATION AND PROCESS THEREOF 125
Caratterizzazione e modellazione del comportamento meccanicodella valvola di un pMDI. 124
"Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs 123
Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting 123
Crystallization of stable doped mannitol polymorphs and in vitro assessment of their safety as carriers for lung delivery 123
Chimeral agglomerates of microparticles for nasal administration of analgesic drug powders 121
Engineered sodium hyaluronate respirable dry powders for pulmonary drug delivery 121
Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2 120
Dose administration manoeuvres and patient care in tobramycin dry powder inhalation therapy 119
Therapeutic effect of cyclosporine A-loading TPGS micelles on a mouse model of LPS-induced neuroinflammation 118
Respicell(TM): An innovative dissolution apparatus for inhaled products 118
Carrageenan from red algae: an application in the development of inhalable tuberculosis therapy targeting the macrophages 117
Microparticles comprising a salt of 8-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone having improved adhesion properties for dry powder inhalation 116
Mannitol polymorphs as carrier in dpis formulations: Isolation characterization and performance 115
Design and Characterization of Maltoheptaose-b-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen 114
Nebulized coenzyme Q10 nanosuspensions: A versatile approach for pulmonary antioxidant therapy 113
A dry powder formulation for peripheral lung delivery and absorption of an anti-SARS-CoV-2 ACE2 decoy polypeptide 111
Respirable amikacin dry powders for inhalation by a Quality bu Design procedure 110
Characterisation of Particles Emitted from Two Formulations of Beclomethasone Dipropionate Solution Metered Dose Inhalers 110
Nasal delivery as a strategy for the prevention and treatment of COVID-19 109
Pulmonary Spray Dried Powders of Tobramycin Containing Sodium Stearate to Improve Aerosolization Efficiency 109
Layered lipid microcapsules for mesalazine delayed-release in children 106
Dry Coating Technique for Inhalation Powders 106
Clinically Relevant Characterization and Comparison of Ryaltris and Other Anti-Allergic Nasal Sprays 105
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 105
Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure 104
Compositions in powder form made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 104
Evaluation of the Physico-mechanical Properties and Electrostatic Charging Behavior of Different Capsule Types for Inhalation Under Distinct Environmental Conditions 104
The role of lipophilic adjuvant to produce high respirable tobramicin powders for inhalation 104
The development of amikacin dry powder for pulmonary administration 103
The role of airways microbiota on local and systemic diseases: a rationale for probiotics delivery to the respiratory tract 102
The application of Quality by Design framework in the pharmaceutical development of dry powder inhalers 102
Complex product composition generates risks for generic substitution also with dosage forms for intravenous administration 101
Back to Basics: The development of a simple, homogenous, two-component dry powder inhaler formulation for the delivery of budesonide using miscible vinyl polymers. 101
Sodium Hyaluronate Microparticles for Pulmonary Delivery of Anti-mycobacterial Drugs 100
Performance of Different Nebulizers in the Aerosolization of Colistimethate Sodium 100
POLVERI NASALI DI MORFINA PER UNA RAPIDA ANALGESIA 100
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances 99
Polysaccharides: New Frontiers for Nasal Administration of Medicines 99
Compositions in powder from made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 99
Formulation Strategies for Antitubercular Drugs by Inhalation 99
Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler® in Comparison with Diskus® and Turbohaler® Dry Powder Inhalers 99
Particles comprising a salt of 8-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino] ethyl]-2(1h)-quinolinone having improved adhesion properties for powder formulations for inhalation 98
Ex vivo permeation of tamoxifen and its 4-OH metabolite through rat intestine from lecithin/chitosan nanoparticles 97
Multivariate Analysis of Effects of Asthmatic Patient Respiratory Profiles on the in Vitro Performance of a Reservoir Multidose and a Capsule-Based Dry Powder Inhaler 97
Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect 96
High Respirable Insulin Dry Powder for Pulmonary Administration 95
Aerodynamic assessment for inhalation products: fundamentals and current pharmacopoeial methods 95
Spray dried amikacin powder for inhalation in cystic fibrosis patients: A quality by design approach for product construction 95
Particles and powders: Tools of innovation for non-invasive drug administration 94
The impact of lipid corona on rifampicin intramacrophagic transport using inhaled solid lipid nanoparticles surface-decorated with a mannosylated surfactant 94
Resistant tuberculosis: The latest advancements of second-line antibiotic inhalation products 94
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs 93
Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: Loading, enzyme-trigger release and cell uptake 93
The role of the solid state and physical properties of the carrier in adhesive mixtures for lung delivery 93
Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation 93
Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients 92
The Influence of Energy Input During Dry Powder Blending on Dynamic Flow Properties, Powder Aerosolization and Dissolution of Dry Powders for Inhalation 91
Inhalable spray-dried chondroitin sulphate microparticles: Effect of different solvents on particle properties and drug activity 91
Effect of polymers for aerolization properties of mannitol-based microcomposites containing meloxicam 90
Drug Delivery Strategies for Pulmonary Administration of Antibiotics 90
Hybrid Nanoparticles as a Novel Tool for Regulating Psychosine-Induced Neuroinflammation and Demyelination In Vitro and Ex vivo 90
chimerical agglomerates of microparticles for nasal administration of analgesic drug powders 89
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs (vol 631, 122478, 2023) 88
AEROSOLIZED SULFATED HYALURONAN DERIVATIVES PROLONG THE SURVIVAL OF K18 ACE2 MICE INFECTED WITH A LETHAL DOSE OF SARS-COV-2 88
Multilayer PVA adsorption onto hydrophobic drug substrates to engineer drug-rich microparticles 87
100 years of drug delivery to the lungs 87
Micro/nanosystems and biomaterials for controlled delivery of antimicrobial and anti-biofilm agents 87
INHALATION DRUG DELIVERY Techniques and Products 87
Floating modular drug delivery systems with buoyancy independent of release mechanisms to sustain amoxicillin and clarithromycin intra-gastric concentrations 87
Influence of Sodium Stearate on Amikacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis Patients with Pseudomonas Aeruginosa Lung Infections 86
Novel Dry Hyaluronic Acid–Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis 86
Nanostructures for overcoming the pulmonary barrier: drug delivery strategies 85
Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways 84
Nasal Powders of Morphine Microcrystal Agglomerates 84
Totale 11.304
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.250
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021379 0 0 0 0 0 44 90 39 92 36 55 23
2021/2022591 12 7 14 32 37 36 64 58 38 39 19 235
2022/20232.342 244 218 132 186 175 254 29 166 774 31 97 36
2023/20241.220 56 79 24 60 93 205 222 89 34 87 111 160
2024/20253.505 88 184 223 292 305 386 195 150 385 347 295 655
2025/20263.950 611 647 949 662 1.013 68 0 0 0 0 0 0
Totale 14.235